These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14521520)

  • 21. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.
    Ziegler A; Luedke GH; Fabbro D; Altmann KH; Stahel RA; Zangemeister-Wittke U
    J Natl Cancer Inst; 1997 Jul; 89(14):1027-36. PubMed ID: 9230884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
    Gautschi O; Tschopp S; Olie RA; Leech SH; Simões-Wüst AP; Ziegler A; Baumann B; Odermatt B; Hall J; Stahel RA; Zangemeister-Wittke U
    J Natl Cancer Inst; 2001 Mar; 93(6):463-71. PubMed ID: 11259472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation.
    Kieslinger M; Woldman I; Moriggl R; Hofmann J; Marine JC; Ihle JN; Beug H; Decker T
    Genes Dev; 2000 Jan; 14(2):232-44. PubMed ID: 10652277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bcl-2 antisense oligodeoxynucleotide enhances araninosyl cytosine-induced apoptosis of primary leukemia cells].
    Lei XY; Zhang H; He DM
    Ai Zheng; 2002 Dec; 21(12):1301-4. PubMed ID: 12520735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
    Nuessler V; Stötzer O; Gullis E; Pelka-Fleischer R; Pogrebniak A; Gieseler F; Wilmanns W
    Leukemia; 1999 Nov; 13(11):1864-72. PubMed ID: 10557064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils.
    Epling-Burnette PK; Zhong B; Bai F; Jiang K; Bailey RD; Garcia R; Jove R; Djeu JY; Loughran TP; Wei S
    J Immunol; 2001 Jun; 166(12):7486-95. PubMed ID: 11390502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line.
    Rosa Santos SC; Dumon S; Mayeux P; Gisselbrecht S; Gouilleux F
    Oncogene; 2000 Feb; 19(9):1164-72. PubMed ID: 10713704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells.
    de Groot RP; Raaijmakers JA; Lammers JW; Jove R; Koenderman L
    Blood; 1999 Aug; 94(3):1108-12. PubMed ID: 10419904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of STAT5 triggers proliferation and contributes to anti-apoptotic signalling mediated by the oncogenic Xmrk kinase.
    Morcinek JC; Weisser C; Geissinger E; Schartl M; Wellbrock C
    Oncogene; 2002 Mar; 21(11):1668-78. PubMed ID: 11896598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antisense abrogation of DENN expression induces apoptosis of leukemia cells in vitro, causes tumor regression in vivo and alters the transcription of genes involved in apoptosis and the cell cycle.
    Lim KM; Yeo WS; Chow VT
    Int J Cancer; 2004 Mar; 109(1):24-37. PubMed ID: 14735464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of WT1 gene expression on cell growth and proliferation in myeloid leukemia cell lines.
    Mi Y; Wang L; Bian S; Meng Q; Chen G; Wang J
    Chin Med J (Engl); 1999 Aug; 112(8):705-8. PubMed ID: 11601276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
    Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antisense oligodeoxynucleotides to bax mRNA promote survival of rat sympathetic neurons in culture.
    Gillardon F; Zimmermann M; Uhlmann E; Krajewski S; Reed JC; Klimaschewski L
    J Neurosci Res; 1996 Mar; 43(6):726-34. PubMed ID: 8984202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced glycation end product-induced proliferation in NRK-49F cells is dependent on the JAK2/STAT5 pathway and cyclin D1.
    Guh JY; Huang JS; Chen HC; Hung WC; Lai YH; Chuang LY
    Am J Kidney Dis; 2001 Nov; 38(5):1096-104. PubMed ID: 11684565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
    Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed neutrophil apoptosis in bovine subclinical mastitis.
    Boutet P; Boulanger D; Gillet L; Vanderplasschen A; Closset R; Bureau F; Lekeux P
    J Dairy Sci; 2004 Dec; 87(12):4104-14. PubMed ID: 15545372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
    Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
    J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells.
    Huang M; Dorsey JF; Epling-Burnette PK; Nimmanapalli R; Landowski TH; Mora LB; Niu G; Sinibaldi D; Bai F; Kraker A; Yu H; Moscinski L; Wei S; Djeu J; Dalton WS; Bhalla K; Loughran TP; Wu J; Jove R
    Oncogene; 2002 Dec; 21(57):8804-16. PubMed ID: 12483533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FVIIa:TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production.
    Versteeg HH; Spek CA; Slofstra SH; Diks SH; Richel DJ; Peppelenbosch MP
    Circ Res; 2004 Apr; 94(8):1032-40. PubMed ID: 15016732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells.
    Yamashita H; Iwase H; Toyama T; Fujii Y
    Oncogene; 2003 Mar; 22(11):1638-52. PubMed ID: 12642867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.